14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.399 1 day ( 0 % )
Last Price $1.74 0.578 %
High/ Low $1.72 - $1.77 6.40%
Chg 7 Days 4.19 % $1.67 $1.74
Chg 30 Days 1.75 % $1.71 $1.74
Chg 12 mos -82.12 % $9.73 $1.74
Trend - 3 mos 4.15 % Width: 10.01 %
Trend - 12 mos -64.63 % Width: 347.59 %
Pred. range - 3 mos $1.71 - $1.88 -1.65 % - 8.19 %
Pred. range - 12 mos N/A - $1.61 -100.00 % - -7.67 %
Short MA avg 3 mos Buy Apr 30, 2024 - 4 days
Long MA avg 3 mos Buy Apr 30, 2024 - 4 days
Short/Long MA avg 3 mos Buy May 02, 2024 - 2 days
Short MA avg 12 mos Buy Apr 30, 2024 - 4 days
Long MA avg 12 mos Sell Dec 13, 2023 - 98 days
Short/Long MA avg 12 mos Sell Nov 22, 2023 - 112 days
Pivot Short Buy Apr 25, 2024 - 7 days
Bollinger Buy Apr 18, 2024 - 12 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals. Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycog... RPHM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT